Genetic testing helps predict disease recurrence in myelodysplastic syndrome | The Source | Washington University in St. Louis
A DNA-based analysis of blood cells soon after a stem cell transplant can predict likelihood of disease recurrence in patients with myelodysplastic syndrome (MDS), a group of cancerous disorders characterized by dysfunctional blood cells, according to new research at the School of Medicine.